Markets
Analysts shrug off Oklo’s wider loss
(CSA Archives/Getty Images)

Analysts shrug off Oklo’s deeper-than-expected loss

They’re giving the company — which still has zero revenue and widening losses — credit for getting crucial support and approvals from the US government.

Shares of high-flying retail favorite Oklo rose Wednesday after the developer of modular nuclear reactors reported a wider-than-expected loss Tuesday after the close.

Analysts seemed to give the company credit for making regulatory progress on its plan to develop smaller modular reactors that use different technology than traditional water-cooled nuclear power plants.

These so-called “experimental breeder reactors,” or EBRs, use liquid metal — in Oklo’s case, liquid sodium — to cool metallic fuel made of uranium alloys, rather than the traditional form of fuel used in nuclear reactors: ceramic-covered uranium pellets contained in fuel rods that are cooled with vast amounts of water, making them nearly impossible to build compactly.

The company is currently building its first product, a reactor it calls Aurora, at the US Energy Department’s primary nuclear energy research and development center, the Idaho National Laboratory. The reactor is expected to be completed sometime in late 2027 or 2028. The company broke ground on the project in September.

Analysts gave Oklo credit for hitting recent milestones, including receiving Department of Energy approval of a safety plan for the facility it will use to make the fuel for its reactor in only two weeks, under a DOE pilot program designed to speed reviews directed by Trump administration executive orders.

The approval of the safety design “marks a key milestone,” wrote analyst Jed Dorsheimer of William Blair, adding that the approval is “reinforcing its leadership in next generation nuclear fuel.”

Bank of America analyst Dimple Gosai wrote that the “rapid two-week approval of Oklo’s INL Fuel Fabrication Facility NSDA reflects strong agency backing.”

Separately, in its earnings results Oklo highlighted that it received approval for its Pluto A test reactor to pursue authorizations for building its experimental reactors through the Department of Energy without having to wait for full commercial approvals of its reactors from the Nuclear Regulatory Council.

“Oklo continues to see regulatory acceleration for its projects with the DOE authorizing an approval to construct and operate a nuclear facility creating a modern pathway to get new nuclear plants built quickly with operating facilities having an option to transition to NRC licensing and oversight for full commercial operations,” Wedbush Securities analyst Dan Ives wrote.

While the company’s close ties to the Trump administration — the current secretary of energy is a former Oklo board member — are seen as an advantage by the market, analysts note that the money-losing, zero-revenue company remains a speculative investment.

“While we recognize the inherent risks of a pre-revenue business, we maintain our outperform rating, viewing Oklo as best-in-class and a leading beneficiary of structural growth in nuclear energy and sustained federal support,” Dorsheimer wrote.

Shortly before midday in New York, Oklo shares were up more than 420% in 2025.

More Markets

See all Markets
markets

Intel soars amid retail engagement, analyst chatter

Intel ripped toward a new 52-week high Wednesday, amid a flurry of activity in the options market and a couple of positive analyst assessments ahead of its earnings report due tomorrow.

Shortly after 11 a.m. ET, call options activity was roughly equivalent to the full-day average over the past 10 sessions. Bets on stock swings using call options have become a highly popular retail trade, suggesting that retail investors are getting interested in the shares ahead of the report from the partially nationalized American chip icon.

(That interpretation is buttressed by what we’re seeing on social sentiment-monitoring sites like SwaggyStocks, which at about 11:30 a.m. listed Intel as the fifth-most-mentioned stock on Reddit’s r/WallStreetBets forum over the past 24 hours.)

Wall Street analysts are also chattering about the stock, with RBC and Bernstein Research both writing about it in the last 24 hours.

RBC — which has a “sector perform” (or neutral) rating on Intel — said it expects a “slight beat and largely inline outlook” when the company reports after the close Thursday.

Bernstein’s Intel watchers — who have a “market perform” (also neutral) rating on the stock — seemed a bit more cautious, writing, “Overall numbers going forward still looking high to us. Fundamentals and valuation keep us sidelined.”

markets

BNP upgrades Seagate on more durable cycle

Seagate Technology Holdings was up in early trading after analysts at BNP Paribas upgraded the shares to “outperform” from “neutral” and lifted their price target to $380 a share, implying a gain of almost 15% from where the stock is currently trading.

The maker of the somewhat stodgy technology known as hard disk drives — or HDDs in tech lingo — was one of the top stocks in the S&P 500 for much of last year as it was swept up in the AI data center trade.

Data centers need tons of storage capacity, and demand from hyperscalers has driven up prices and created shortages for disk drives, an industry that is dominated by a duopoly of Seagate and Western Digital. (BNP also maintained its “outperform” rating on WDC in a note Wednesday.)

The analysts at BNP say they pushed by the buy button on the stock after becoming more convinced that the upswing in sales was durable, writing:

“We have witnessed a structural shift happening in HDD industry, toward 1) an effective duopoly, 2) higher mix toward data centers, and 3) disciplined capex investments. These have supported our expectations of long-term, through-cycle profitability for the HDD industry. We are now upgrading Seagate from Neutral to Outperform as we are gaining greater conviction that robust data center storage demand could drive an upcycle longer than we initially expected. We think a secular re-rating of Seagate (as well as Western Digital) to over 20x is justified.”

“We have witnessed a structural shift happening in HDD industry, toward 1) an effective duopoly, 2) higher mix toward data centers, and 3) disciplined capex investments. These have supported our expectations of long-term, through-cycle profitability for the HDD industry. We are now upgrading Seagate from Neutral to Outperform as we are gaining greater conviction that robust data center storage demand could drive an upcycle longer than we initially expected. We think a secular re-rating of Seagate (as well as Western Digital) to over 20x is justified.”

markets

Stocks jump as Trump says “I won’t use force” to acquire Greenland

In a speech in Davos, Switzerland, US President Donald Trump said he won’t use force to acquire Greenland, sending stocks higher at the open. 

“We probably won't get anything unless I decide to use excessive strength and force, where we would be frankly unstoppable, but I won’t do that,” Trump told the crowd, referring to his pursuit of Greenland, which has roiled markets recently. “People thought I would use force. I don’t have to use force. I don’t want to use force. I won’t use force.” 

He seemed to indicate that Denmark, which owns Greenland, could rebuff the US’s overtures to acquire the country without military retaliation.

“They have a choice. You can say yes and we will be very appreciative. Or you can say no and we will remember,” he said. Throughout his speech, Trump constantly reiterated his desire for the US to own Greenland.

Stocks rose at the open, with the S&P 500 rising 0.3%. S&P 500 futures, which had been down Wednesday morning, jumped after his comments.

markets

J&J slips despite cheery 2026 guidance

Johnson & Johnson reported fourth-quarter sales that beat expectations and gave rosy guidance for 2026.

The company said it expects to bring in between $100 billion and $101 billion in revenue this year, compared to the $98.9 billion analysts polled by FactSet were expecting. The drugmaker also expects to report between $11.43 and $11.63 in annual adjusted earnings per share, compared to the $11.48 that Wall Street was expecting.

Despite beating expectations, J&J, the first major drugmaker to report earnings results this year, fell by more than 2% in premarket trading.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.